Boonton, NJ, United States of America

Christopher Lee Parks

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 81(Granted Patents)


Location History:

  • Boonton, NJ (US) (2003 - 2023)
  • New York, NY (US) (2017 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher Lee Parks

Introduction

Christopher Lee Parks, based in Boonton, New Jersey, is a distinguished inventor with a remarkable portfolio comprising 21 patents. His work primarily focuses on recombinant viral vectors, which hold significant potential in the field of vaccine development, particularly for infectious diseases such as AIDS.

Latest Patents

Parks' recent patents include groundbreaking technologies related to recombinant vesicular stomatitis viruses. These patents detail innovative methods for using these viruses as both prophylactic and therapeutic vaccines. Specifically, one patent encompasses the preparation and purification of immunogenic compositions formulated into vaccines aimed at combatting infectious diseases. This research highlights the advancement of vaccine technology and the potential for new treatments to improve global health outcomes.

Career Highlights

Throughout his career, Christopher has made substantial contributions to the field of immunology and vaccine research. He has collaborated with prominent organizations, including the International Aids Vaccine Initiative and Wyeth Holdings Corporation. His dedication to innovative research has positioned him at the forefront of vaccine development, making his insights and discoveries crucial to addressing pandemics and other infectious diseases.

Collaborations

Parks has had the opportunity to work alongside talented individuals such as Maoli Yuan and Ivo Lorenz. This collaborative spirit has fostered an environment where innovative ideas can flourish, leading to breakthroughs in the application of recombinant viral vectors for vaccines.

Conclusion

Christopher Lee Parks continues to be an influential figure in the landscape of vaccine innovation. His extensive work and numerous patents reflect a commitment to enhancing public health through cutting-edge research. As the world faces ongoing challenges related to infectious diseases, Parks' contributions remain vital for advancing medical science and ultimately protecting global health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…